Last updated: August 18, 2026

Examiner: TRAN, ERIC

Tech Center 1600 • Art Units: 1629

This examiner grants 70% of resolved cases

Performance Statistics

69.8%

Allow Rate

+9.8% vs TC avg

139

Total Applications

+24.0%

Interview Lift

1019

Avg Prosecution Days

Based on 106 resolved cases, 2023–2026

2.2%

§101 Eligibility

16.7%

§102 Novelty

30.3%

§103 Obviousness

33.3%

§112 Clarity

App #	Title	Status	Assignee
19453621	COMBINATION THERAPY FOR A DOPAMINE AGONIST	Non-Final OA	Alto Neuroscience, Inc.
18559184	WDR5 INHIBITORS AND MODULATORS	Final Rejection	Vanderbilt University
18556964	SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER	Final Rejection	The Johns Hopkins University
17781929	METHOD OF TREATMENT WITH KCNQ CHANNEL OPENERS	Final Rejection	Icahn School of Medicine at Mount Sinai

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.